These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 14984763)

  • 1. Role of lymphangiogenic factors in tumor metastasis.
    He Y; Karpanen T; Alitalo K
    Biochim Biophys Acta; 2004 Mar; 1654(1):3-12. PubMed ID: 14984763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.
    Saharinen P; Tammela T; Karkkainen MJ; Alitalo K
    Trends Immunol; 2004 Jul; 25(7):387-95. PubMed ID: 15207507
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting lymphangiogenesis to prevent tumour metastasis.
    Achen MG; Mann GB; Stacker SA
    Br J Cancer; 2006 May; 94(10):1355-60. PubMed ID: 16641900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of lymphangiogenesis.
    Takahashi M; Yoshimoto T; Kubo H
    Int J Hematol; 2004 Jul; 80(1):29-34. PubMed ID: 15293565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-induced lymphangiogenesis: a target for cancer therapy?
    Thiele W; Sleeman JP
    J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphangiogenesis and tumor progression].
    Vittet D; Feige JJ
    Bull Cancer; 2007 Oct; 94(10):881-6. PubMed ID: 17964982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis.
    Matsumoto M; Roufail S; Inder R; Caesar C; Karnezis T; Shayan R; Farnsworth RH; Sato T; Achen MG; Mann GB; Stacker SA
    Clin Exp Metastasis; 2013 Aug; 30(6):819-32. PubMed ID: 23591595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangiogenic growth factors as markers of tumor metastasis.
    Stacker SA; Williams RA; Achen MG
    APMIS; 2004; 112(7-8):539-49. PubMed ID: 15563315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the molecular control of the lymphatic vascular system and its role in disease.
    Cueni LN; Detmar M
    J Invest Dermatol; 2006 Oct; 126(10):2167-77. PubMed ID: 16983326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.
    Krishnan J; Kirkin V; Steffen A; Hegen M; Weih D; Tomarev S; Wilting J; Sleeman JP
    Cancer Res; 2003 Feb; 63(3):713-22. PubMed ID: 12566318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of lymphangiogenic markers in human gastroenteric tumor.
    Yuanming L; Feng G; Lei T; Ying W
    Arch Med Res; 2007 Jan; 38(1):106-12. PubMed ID: 17174733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lymphatic vasculature: recent progress and paradigms.
    Oliver G; Alitalo K
    Annu Rev Cell Dev Biol; 2005; 21():457-83. PubMed ID: 16212503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanisms of lymphatic development].
    Kubo H
    Seikagaku; 2004 Sep; 76(9):1210-6. PubMed ID: 15524110
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular targeting of lymphatics for therapy.
    Stacker SA; Hughes RA; Achen MG
    Curr Pharm Des; 2004; 10(1):65-74. PubMed ID: 14754406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphangiogenesis and lymphatic function in periodontal disease.
    Berggreen E; Wiig H
    J Dent Res; 2013 Dec; 92(12):1074-80. PubMed ID: 24029591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
    Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
    Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels.
    He Y; Rajantie I; Pajusola K; Jeltsch M; Holopainen T; Yla-Herttuala S; Harding T; Jooss K; Takahashi T; Alitalo K
    Cancer Res; 2005 Jun; 65(11):4739-46. PubMed ID: 15930292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.